AntriaBio

AntriaBio

AntriaBio

AntriaBio is developing proprietary products in sustained release injectable formulations including AB101, a once-a-week basal insulin. $ANTB
Type
B2b
Founded
2010
Raised
$44.4M
Follow us
Alexa global traffic share